DE69920683D1 - Selektiv auf den cb2-rezeptor wirkende cannabinoide - Google Patents

Selektiv auf den cb2-rezeptor wirkende cannabinoide

Info

Publication number: DE69920683D1
Authority: DE; Germany
Prior art keywords: receptor; selective; cannabinoids; cannabinoid; novel
Prior art date: 1998-05-04
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

DE69920683T

Other languages

English (en)

Other versions

DE69920683T2 (de

Inventor

Alexandros Makriyannis

Atmaram Khanolkar

Dai Lu

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

University of Connecticut

Original Assignee

University of Connecticut

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-05-04

Filing date

1999-05-04

Publication date

2004-11-04

1999-05-04 Application filed by University of Connecticut filed Critical University of Connecticut

2004-11-04 Application granted granted Critical

2004-11-04 Publication of DE69920683D1 publication Critical patent/DE69920683D1/de

2005-04-07 Publication of DE69920683T2 publication Critical patent/DE69920683T2/de

2019-05-05 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

229930003827 cannabinoid Natural products 0.000 title abstract 6
239000003557 cannabinoid Substances 0.000 title abstract 6
229940065144 cannabinoids Drugs 0.000 title abstract 3
102000009135 CB2 Cannabinoid Receptor Human genes 0.000 abstract 1
108010073376 CB2 Cannabinoid Receptor Proteins 0.000 abstract 1
125000002837 carbocyclic group Chemical group 0.000 abstract 1
125000000623 heterocyclic group Chemical group 0.000 abstract 1
210000000987 immune system Anatomy 0.000 abstract 1
230000001506 immunosuppresive effect Effects 0.000 abstract 1
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DE69920683T 1998-05-04 1999-05-04 Selektiv auf den CB2-Rezeptor wirkende Cannabinoide Expired - Fee Related DE69920683T2 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US8412998P	1998-05-04	1998-05-04
US84129P		1998-05-04
PCT/US1999/009806 WO1999057107A2 (en)	1998-05-04	1999-05-04	Cannabinoids selective for the cb2 receptor

Publications (2)

Publication Number	Publication Date
DE69920683D1 true DE69920683D1 (de)	2004-11-04
DE69920683T2 DE69920683T2 (de)	2005-04-07

Family

ID=22183058

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE69920683T Expired - Fee Related DE69920683T2 (de)	1998-05-04	1999-05-04	Selektiv auf den CB2-Rezeptor wirkende Cannabinoide

Country Status (7)

Country	Link
US (1)	US6166066A (de)
EP (1)	EP1076653B1 (de)
AT (1)	ATE277921T1 (de)
CA (1)	CA2340444A1 (de)
DE (1)	DE69920683T2 (de)
ES (1)	ES2224658T3 (de)
WO (1)	WO1999057107A2 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE277921T1 (de) *	1998-05-04	2004-10-15	Univ Connecticut	Selektiv auf den cb2-rezeptor wirkende cannabinoide
CA2340445A1 (en) *	1998-05-04	1999-11-11	The University Of Connecticut	Novel analgesic and immunomodulatory cannabinoids
US7589220B2 (en)	1998-06-09	2009-09-15	University Of Connecticut	Inhibitors of the anandamide transporter
US7897598B2 (en)	1998-06-09	2011-03-01	Alexandros Makriyannis	Inhibitors of the anandamide transporter
US7276613B1 (en)	1998-11-24	2007-10-02	University Of Connecticut	Retro-anandamides, high affinity and stability cannabinoid receptor ligands
US7161016B1 (en)	1998-11-24	2007-01-09	University Of Connecticut	Cannabimimetic lipid amides as useful medications
US20070179135A1 (en) *	2006-01-05	2007-08-02	Travis Craig R	Cannabinoid derivatives
US6900236B1 (en)	1999-10-18	2005-05-31	University Of Connecticut	Cannabimimetic indole derivatives
US7741365B2 (en) *	1999-10-18	2010-06-22	University Of Connecticut	Peripheral cannabinoid receptor (CB2) selective ligands
US7119108B1 (en)	1999-10-18	2006-10-10	University Of Connecticut	Pyrazole derivatives as cannabinoid receptor antagonists
US8084467B2 (en) *	1999-10-18	2011-12-27	University Of Connecticut	Pyrazole derivatives as cannabinoid receptor antagonists
US6943266B1 (en) *	1999-10-18	2005-09-13	University Of Connecticut	Bicyclic cannabinoid agonists for the cannabinoid receptor
CA2387764A1 (en)	1999-10-18	2001-04-26	University Of Connecticut	Peripheral cannabinoid receptor (cb2) selective ligands
US7393842B2 (en) *	2001-08-31	2008-07-01	University Of Connecticut	Pyrazole analogs acting on cannabinoid receptors
DE60125541T2 (de) *	2000-06-22	2007-10-11	Pharmos Corp.	Neue nicht psychotropische cannabinoide
US7235584B2 (en) *	2000-06-22	2007-06-26	Pharmos Corporation	Non-psychotropic cannabinoids
EP1361876A4 (de) *	2001-01-26	2004-03-31	Univ Connecticut	Neue cannabimimetische liganden
DE60237431D1 (de)	2001-01-29	2010-10-07	Univ Connecticut	Rezeptor-selektive cannabimimetische aminoalkylindole
JP4312594B2 (ja) *	2001-07-13	2009-08-12	ユニバーシティオブコネチカット	新規な二環式及び三環式カンナビノイド
US7666867B2 (en) *	2001-10-26	2010-02-23	University Of Connecticut	Heteroindanes: a new class of potent cannabimimetic ligands
EP1461027A4 (de) *	2001-12-07	2005-09-07	Univ Virginia Commonwealth	Behandlung von neoplasie
WO2003075917A1 (en)	2002-03-08	2003-09-18	Signal Pharmaceuticals, Inc.	Combination therapy for treating, preventing or managing proliferative disorders and cancers
DE60320784D1 (de) *	2002-06-06	2008-06-19	Yissum Res Dev Co	Stände zur modulierung des knochenwachstums
AU2003265663A1 (en)	2002-08-23	2004-03-11	University Of Connecticut	Keto cannabinoids with therapeutic indications
IL160420A0 (en) *	2004-02-16	2004-07-25	Yissum Res Dev Co	Treating or preventing diabetes with cannabidiol
EP1758566A2 (de) *	2004-06-22	2007-03-07	Pharmos Limited	Verwendung von agonisten des cb-2-rezeptors zur behandlung von chorea huntington
US7781650B2 (en) *	2007-04-30	2010-08-24	Monsanto Technology Llc	Plants and seeds of corn variety CV202909
US9575319B2 (en)	2014-03-10	2017-02-21	Ion Virtual Technology Corporation	Method and system for reducing motion blur when experiencing virtual or augmented reality environments
US10239808B1 (en)	2016-12-07	2019-03-26	Canopy Holdings, LLC	Cannabis extracts
EP3509638B1 (de)	2017-06-20	2022-01-12	Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.	Cannabidiolsäureesterzusammensetzungen und verwendungen davon
CA3089994A1 (en)	2018-01-31	2019-08-08	Canopy Holdings, LLC	Hemp powder
WO2020077153A1 (en)	2018-10-10	2020-04-16	Canopy Holdings, LLC	Synthesis of cannabigerol
US12403114B2 (en)	2019-03-12	2025-09-02	Epm (Ip), Inc.	Cannabinoid acid ester compositions and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3915996A (en) *	1972-10-16	1975-10-28	Abbott Lab	Process for making benzopyrans
US3886184A (en) *	1973-08-03	1975-05-27	Lilly Co Eli	Aminodibenzo(b,d)pyrans
US4833073A (en) *	1987-01-27	1989-05-23	Hoffmann-La Roche Inc.	Immunoassay for tetrahydrocannabinol metabolites
US5440052A (en) *	1993-08-06	1995-08-08	University Of Connecticut	Compositions useful as a cannabinoid receptor probe
FR2735774B1 (fr) *	1995-06-21	1997-09-12	Sanofi Sa	Utilisation de composes agonistes du recepteur cb2 humain pour la preparation de medicaments immunomodulateurs, nouveaux composes agonistes du recepteur cb2 et les compositions pharmaceutiques les contenant
US5688825A (en) *	1996-05-31	1997-11-18	University Of Connecticut	Anandamide amidase inhibitors as analgesic agents
ATE277921T1 (de) *	1998-05-04	2004-10-15	Univ Connecticut	Selektiv auf den cb2-rezeptor wirkende cannabinoide
CA2340445A1 (en) *	1998-05-04	1999-11-11	The University Of Connecticut	Novel analgesic and immunomodulatory cannabinoids

1999
- 1999-05-04 AT AT99921676T patent/ATE277921T1/de not_active IP Right Cessation
- 1999-05-04 CA CA002340444A patent/CA2340444A1/en not_active Abandoned
- 1999-05-04 US US09/304,718 patent/US6166066A/en not_active Expired - Fee Related
- 1999-05-04 WO PCT/US1999/009806 patent/WO1999057107A2/en not_active Ceased
- 1999-05-04 DE DE69920683T patent/DE69920683T2/de not_active Expired - Fee Related
- 1999-05-04 ES ES99921676T patent/ES2224658T3/es not_active Expired - Lifetime
- 1999-05-04 EP EP99921676A patent/EP1076653B1/de not_active Expired - Lifetime

Also Published As

Publication number	Publication date
WO1999057107A2 (en)	1999-11-11
EP1076653B1 (de)	2004-09-29
US6166066A (en)	2000-12-26
CA2340444A1 (en)	1999-11-11
ATE277921T1 (de)	2004-10-15
WO1999057107A3 (en)	2000-02-03
DE69920683T2 (de)	2005-04-07
ES2224658T3 (es)	2005-03-01
EP1076653A2 (de)	2001-02-21

Similar Documents

Publication	Publication Date	Title
DE69920683D1 (de)	2004-11-04	Selektiv auf den cb2-rezeptor wirkende cannabinoide
NO992353D0 (no)	1999-05-14	Rensing av neurotrofiner
EA199700156A1 (ru)	1997-12-30	Производные индола как антагонисты рецептора 5-нт
ATE175198T1 (de)	1999-01-15	N-acylierte trizyklische azaheteroringe verwendbar als vasopressin-antagonisten
TR200000782T2 (tr)	2000-09-21	Resorsinol türevleri.
ATE254456T1 (de)	2003-12-15	Cannabinoid-rezeptor-antagonisten
AR010062A1 (es)	2000-05-17	Nuevos benzamidaldehidos y su utilizacion
DE69910373D1 (de)	2003-09-18	Analgetische und immunomodulierende cannabinoiden
NO964236D0 (no)	1996-10-04	Anvendelse av serotonin-antagonister (5HT3) for behandling av fibromyalgi
ATE270663T1 (de)	2004-07-15	Trizyklische 1-benzylpyrazol-3- carbonsäurederivate als cannabinoidrezeptorantagonisten
EA200100012A1 (ru)	2001-08-27	Мостиковые инденопирролокарбазолы
TR199900501T2 (xx)	1999-07-21	Benzamin t�revleri ve bunlar�n ila� olarak kullan�m�.
DZ1468A1 (fr)	2004-09-13	Composés nouveaux.
ATE289810T1 (de)	2005-03-15	Ecteinascidinderivate
ES8505539A1 (es)	1985-06-01	Procedimiento para la obtencion de derivados de alcohol bencilico con propiedades sebosupresoras
EA199700242A1 (ru)	1998-04-30	Индазолкарбоксамиды, способ их получения, фармкомпозиция и способ ингибирования 5-нтрецептора
ES2171911T3 (es)	2002-09-16	Poliaminas conformacionalmente restringidas y su uso como agentes antineoplasicos.
DK0983275T3 (da)	2002-12-23	Nye triptolidderivater, der er nyttige til behandling af autoimmune sygdomme
DE69707098D1 (de)	2001-11-08	Substituierte tetralylmethylenoxindol-analoga als tyrosinkinase-inhibitoren
TR199801612T2 (xx)	1998-11-23	Benzotiofen, benzotiofen i�eren form�ller ve y�ntemler.
EA199800949A1 (ru)	1999-04-29	Антибактериальные соединения карбапенема, содержащие их фармацевтические композиции и способы лечения
ES2140672T3 (es)	2000-03-01	Compuestos biciclicos sustituidos, fusionados y puentes utilizados como agentes terapeuticos.
ES2167725T3 (es)	2002-05-16	Procedimiento para la coloracion de material organico de alto peso molecular, y pigmentos policiclicos.
DE69724000D1 (de)	2003-09-11	Indan- oder dihydroindol-derivate
BR9101438A (pt)	1991-11-26	Processo para preparacao de resina,bem como dispersao aquosa

Legal Events

Date	Code	Title	Description
2005-10-27	8364	No opposition during term of opposition
2010-03-25	8339	Ceased/non-payment of the annual fee